Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 3 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in GBX
The 8 analysts offering 12 month price targets for Oxford BioMedica plc have a median target of 477.50, with a high estimate of 740.00 and a low estimate of 380.00. The median estimate represents a 15.76% increase from the last price of 412.50.
High | 79.4% | 740.00 |
Med | 15.8% | 477.50 |
Low | -7.9% | 380.00 |
Earnings history & estimates in GBX
Average growth rate | +9.53% |
More ▼
Revenue history & estimates in GBP
Average growth rate | +15.43% |
More ▼